Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Size Growth Rate by Type
1.3.2 Services
1.3.3 Assay kits
1.3.4 System
1.4 Market Segment by Application
1.4.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Share by Application (2018-2025)
1.4.2 Hosptial
1.4.3 Clinic
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value 2013-2025
2.1.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production 2013-2025
2.1.3 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Capacity 2013-2025
2.1.4 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2018-2025
2.2.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Size CAGR of Key Regions
2.2.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Capacity by Manufacturers
3.1.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Revenue by Manufacturers (2013-2018)
3.2.2 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Concentration Ratio (CR5 and HHI)
3.3 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Price by Manufacturers
3.4 Key Manufacturers Molecular Human Papillomavirus (HPV) Diagnostic Equipment Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market
3.6 Key Manufacturers Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Services Production and Production Value (2013-2018)
4.1.2 Assay kits Production and Production Value (2013-2018)
4.1.3 System Production and Production Value (2013-2018)
4.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Market Share by Type
4.3 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Market Share by Type
4.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Application
6 Production by Regions
6.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production (History Data) by Regions 2013-2018
6.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Growth Rate 2013-2018
6.3.2 United States Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Growth Rate 2013-2018
6.3.3 Key Players in United States
6.3.4 United States Molecular Human Papillomavirus (HPV) Diagnostic Equipment Import & Export
6.4 Europe
6.4.1 Europe Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Growth Rate 2013-2018
6.4.2 Europe Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Growth Rate 2013-2018
6.4.3 Key Players in Europe
6.4.4 Europe Molecular Human Papillomavirus (HPV) Diagnostic Equipment Import & Export
6.5 China
6.5.3 Key Players in China
6.5.2 China Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Growth Rate 2013-2018
6.5.3 Key Players in China
6.5.4 China Molecular Human Papillomavirus (HPV) Diagnostic Equipment Import & Export
6.6 Japan
6.6.1 Japan Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Growth Rate 2013-2018
6.6.2 Japan Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Growth Rate 2013-2018
6.6.3 Key Players in Japan
6.6.4 Japan Molecular Human Papillomavirus (HPV) Diagnostic Equipment Import & Export
6.7 Other Regions
6.7.1 South Korea
6.7.2 India
6.7.3 Southeast Asia
7 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Regions
7.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption (History Data) by Regions
7.2 North America
7.2.1 North America Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Type
7.2.2 North America Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Application
7.2.3 North America Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Countries
7.2.4 United States
7.2.5 Canada
7.2.6 Mexico
7.3 Europe
7.3.1 Europe Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Type
7.3.2 Europe Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Application
7.3.3 Europe Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Countries
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
7.4 Asia Pacific
7.4.1 Asia Pacific Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Type
7.4.2 Asia Pacific Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Application
7.4.3 Asia Pacific Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Countries
7.4.4 China
7.4.5 Japan
7.4.6 Korea
7.4.7 India
7.4.8 Australia
7.4.9 Indonesia
7.4.10 Thailand
7.4.11 Malaysia
7.4.12 Philippines
7.4.13 Vietnam
7.5 Central & South America
7.5.1 Central & South America Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Type
7.5.2 Central & South America Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Application
7.5.3 Central & South America Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Countries
7.5.4 Brazil
7.6 Middle East and Africa
7.6.1 Middle East and Africa Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Type
7.6.2 Middle East and Africa Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Application
8 Company Profiles
8.1 F. Hoffmann-La Roche Ltd.
8.1.1 F. Hoffmann-La Roche Ltd. Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.1.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.1.5 F. Hoffmann-La Roche Ltd. Recent Development
8.2 Agilent Technologies, Inc.
8.2.1 Agilent Technologies, Inc. Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.2.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.2.5 Agilent Technologies, Inc. Recent Development
8.3 Becton, Dickinson and Company
8.3.1 Becton, Dickinson and Company Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.3.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.3.5 Becton, Dickinson and Company Recent Development
8.4 Qiagen N.V.
8.4.1 Qiagen N.V. Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.4.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.4.5 Qiagen N.V. Recent Development
8.5 Thermo Fisher Scientific Inc.
8.5.1 Thermo Fisher Scientific Inc. Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.5.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.5.5 Thermo Fisher Scientific Inc. Recent Development
8.6 Abbott Laboratories
8.6.1 Abbott Laboratories Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.6.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.6.5 Abbott Laboratories Recent Development
8.7 Hologic Inc.
8.7.1 Hologic Inc. Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.7.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.7.5 Hologic Inc. Recent Development
8.8 Cepheid Inc.
8.8.1 Cepheid Inc. Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.8.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.8.5 Cepheid Inc. Recent Development
8.9 Seegene Inc.
8.9.1 Seegene Inc. Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.9.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.9.5 Seegene Inc. Recent Development
8.10 Takara Bio Inc.
8.10.1 Takara Bio Inc. Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.10.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.10.5 Takara Bio Inc. Recent Development
8.11 DaAn Gene Co., Ltd. of Sun Yat-Sen University
8.12 Promega Corporation
8.13 Greiner Bio-One International GmbH (Greiner Holding AG)
8.14 Enzo Biochem Inc.
8.15 Norgen Biotek Corp.
8.16 DiagCor Bioscience Inc Ltd
8.17 Hybribio Limited
8.18 Zytovision GmbH
8.19 Arbor Vita Corporation
8.20 Medical & Biological Laboratories Co., Ltd
8.21 Fujirebio Diagnostics, Inc.
9 Market Forecast: Production Side
9.1 Production and Production Value Forecast
9.1.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Capacity, Production Forecast 2018-2025
9.1.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Forecast 2018-2025
9.2 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production and Production Value Forecast by Regions
9.2.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Forecast by Regions
9.2.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Forecast by Regions
9.3 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Key Producers Forecast
9.3.1 United States
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.3.5 Other Regions
9.4 Forecast by Type
9.4.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Forecast by Type
9.4.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Forecast by Type
10 Market Forecast: Consumption Side
10.1 Consumption Forecast by Application
10.2 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption Forecast by Countries 2018-2025
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption Forecast by Countries 2018-2025
10.4.2 Germany
10.4.3 France
10.4.4 UK
10.4.5 Italy
10.4.6 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption Forecast by Countries 2018-2025
10.5.2 China
10.5.3 Japan
10.5.4 Korea
10.5.5 India
10.5.6 Australia
10.5.7 Indonesia
10.5.8 Thailand
10.5.9 Malaysia
10.5.10 Philippines
10.5.11 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption Forecast by Country 2018-2025
10.6.2 Brazil
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption Forecast by Countries 2018-2025
10.7.2 Middle East and Africa
10.7.3 GCC Countries
10.7.4 Egypt
10.7.5 South Africa
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales Channels
11.2.2 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Distributors
11.3 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Customers
12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter’s Five Forces Analysis
13 Key Findings
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
【掲載企業】
F. Hoffmann-La Roche Ltd.、Agilent Technologies, Inc.、Becton, Dickinson and Company、Qiagen N.V.、Thermo Fisher Scientific Inc.、Abbott Laboratories、Hologic Inc.、Cepheid Inc.、Seegene Inc.、Takara Bio Inc.、DaAn Gene Co., Ltd. of Sun Yat-Sen University、Promega Corporation、Greiner Bio-One International GmbH (Greiner Holding AG)、Enzo Biochem Inc.、Norgen Biotek Corp.、DiagCor Bioscience Inc Ltd、Hybribio Limited、Zytovision GmbH、Arbor Vita Corporation、Medical & Biological Laboratories Co., Ltd、Fujirebio Diagnostics, Inc.
【免責事項】
https://www.globalresearch.jp/disclaimer